Anaemia in inflammatory bowel disease: a population-based 10-year follow-up.
Fatigue interference with daily living among patients with inflammatory bowel disease.
Mortality and causes of death in Crohn's disease: results from 20 years of follow-up in the IBSEN study.
Five-year outcome after gastric bypass for morbid obesity in a Norwegian cohort.
Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study.
Calprotectin Is a Useful Tool in Distinguishing Coexisting Irritable Bowel-Like Symptoms from That of Occult Inflammation among Inflammatory Bowel Disease Patients in Remission.
Use of complementary and alternative medicine in patients with inflammatory bowel disease: results of a cross-sectional study in Norway.
Fatigue and disease-related worries among inflammatory bowel disease patients in remission; is it a reflection of coexisting IBS-like symptoms? A short report.
Quality of life in patients with inflammatory bowel disease: translation, validity, reliability and sensitivity to change of the Norwegian version of the short health scale (SHS).
Is patient reported outcome (PRO) affected by different follow-up regimens in inflammatory bowel disease (IBD)? A one year prospective, longitudinal comparison of nurse-led versus conventional follow-up.
Health-related quality of life in patients with ulcerative colitis after a 10-year disease course: results from the IBSEN study.
Patients with Crohn's disease experience reduced general health and vitality in the chronic stage: ten-year results from the IBSEN study.
Chronic fatigue is associated with increased disease-related worries and concerns in inflammatory bowel disease.
Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls.
Measuring health-related quality of life in non-complicated diabetes patients may be an effective parameter to assess patients at risk of a more serious disease course: a cross-sectional study of two diabetes outpatient groups.
Worries and Concerns among Inflammatory Bowel Disease Patients Followed Prospectively over One Year.
Appropriateness of early management of newly diagnosed Crohn's disease in a European population-based cohort.
Fecal calprotectin variability in Crohn's disease.
Need for standardization in population-based quality of life studies: a review of the current literature.
Predictive value of serologic markers in a population-based Norwegian cohort with inflammatory bowel disease.
Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study).
IBD patients need in health quality of care ECCO consensus.
Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years.
Effect of phenotype on health care costs in Crohn's disease: A European study using the Montreal classification.
Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort.
Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years.
Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease.
Course of disease, drug treatment and health-related quality of life in patients with inflammatory bowel disease 5 years after initial diagnosis.
Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: psychometric assessments and a comparison with general population norms.
Non-inflammatory joint pain in patients with inflammatory bowel disease is prevalent and has a significant impact on health related quality of life.
The role of quality of care in health-related quality of life in patients with IBD.